Participate in Research

Browse Clinical Trials
MS and GLP-1 Study for UBMD Neurology Patients
Protocol: STUDY00009779
Full Title
Evaluating tolerability and purpose for using Glucagon like peptide -1 (GLP-1) Medications in Persons with Multiple Sclerosis
Description
Are you a patient of UBMD Neurology? Have you been diagnosed with multiple sclerosis (MS)? Are you currently on or have been on in the past GLP-1 medicines? If you, then you might be eligible for a survey study!

A research team from the University at Buffalo is hoping to learn more about how patients with MS tolerate side effects from GLP-1 medicines. These side effects include:
-upset stomach
-nausea
-vomiting
-changes in appetite
-eye changes

Participants will complete two short surveys during a normal clinic visit. The study should last 30 minutes.
Compensation: No
Eligibility
-Adults 18 years or older -Have been diagnosed with multiple sclerosis (MS) -Have previously used a GLP-1 weight-loss medicine -Are currently a patient of UBMD Neurology
Age Group: Adults
Principal Investigator: BIANCA WEINSTOCK-GUTTMAN
Contact(s)
KARA PATRICK
kpatrick@buffalo.edu
+1 716-829-5037

Want to Learn More?

Let us know how the study team can reach you. If you do not hear back within 2 business days, then reach out to the study team directly at the contact information above and someone will assist you.

Your information will be shared only with the research study team and administrative staff for recruitment and will remain confidential. Your information will be stored until study recruitment is closed. Should you no longer want this information to be provided in the aforementioned ways, please contact the study team directly.

Study teams can login to review submissions
Study Team Login